These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27082824)

  • 1. Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.
    Longest PW; Tian G; Khajeh-Hosseini-Dalasm N; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):461-481. PubMed ID: 27082824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.
    Longest PW; Tian G; Walenga RL; Hindle M
    Pharm Res; 2012 Jun; 29(6):1670-88. PubMed ID: 22290350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
    Walenga RL; Longest PW
    J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry powder inhaler aerosol deposition in a model of tracheobronchial airways: Validating CFD predictions with in vitro data.
    Ahookhosh K; Saidi M; Aminfar H; Mohammadpourfard M; Hamishehkar H; Yaqoubi S
    Int J Pharm; 2020 Sep; 587():119599. PubMed ID: 32663586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition and fine particle production during dynamic flow in a dry powder inhaler: a CFD approach.
    Milenkovic J; Alexopoulos AH; Kiparissides C
    Int J Pharm; 2014 Jan; 461(1-2):129-36. PubMed ID: 24296048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined in Vitro-in Silico Approach to Predict Deposition and Pharmacokinetics of Budesonide Dry Powder Inhalers.
    Ruzycki CA; Murphy B; Nathoo H; Finlay WH; Martin AR
    Pharm Res; 2020 Sep; 37(10):209. PubMed ID: 32995953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inspiratory and expiratory aerosol deposition in the upper airway.
    Verbanck S; Kalsi HS; Biddiscombe MF; Agnihotri V; Belkassem B; Lacor C; Usmani OS
    Inhal Toxicol; 2011 Feb; 23(2):104-11. PubMed ID: 21309663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
    Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
    Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.
    Longest W; Hassan A; Farkas D; Hindle M
    Pharm Res; 2022 Feb; 39(2):295-316. PubMed ID: 35147870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerodynamic and electrostatic properties of model dry powder aerosols: a comprehensive study of formulation factors.
    Telko MJ; Hickey AJ
    AAPS PharmSciTech; 2014 Dec; 15(6):1378-97. PubMed ID: 24938617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Tests for Aerosol Deposition. V: Using Realistic Testing to Estimate Variations in Aerosol Properties at the Trachea.
    Wei X; Hindle M; Delvadia RR; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):339-348. PubMed ID: 28332899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational investigation of particle penetration and deposition pattern in a realistic respiratory tract model from different types of dry powder inhalers.
    Kim YH; Li DD; Park S; Yi DS; Yeoh GH; Abbas A
    Int J Pharm; 2022 Jan; 612():121293. PubMed ID: 34808267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting inhaled aerosol delivery to upper airways in children: Insight from computational fluid dynamics (CFD).
    Das P; Nof E; Amirav I; Kassinos SC; Sznitman J
    PLoS One; 2018; 13(11):e0207711. PubMed ID: 30458054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFD Guided Optimization of Nose-to-Lung Aerosol Delivery in Adults: Effects of Inhalation Waveforms and Synchronized Aerosol Delivery.
    Dutta R; Spence B; Wei X; Dhapare S; Hindle M; Longest PW
    Pharm Res; 2020 Sep; 37(10):199. PubMed ID: 32968848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.